Search terms
Results 21 - 30 of 51 - ordered by :
Pages: 1 2 3 4 5 6

A comprehensive approach to cardiovascular prevention Collaboration across disciplines ? nurses, dieticians, physiotherapists, cardiologists and general practitioners - reduces cardiovascular risk ...

Date : 13/06/2008

The EORP Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC), reveals that 65% of patients were taking ...

Date : 18/02/2014

First Joint ESC/EAS Guidelines for the Management of Dyslipidaemias In Europe, as many as one-half of patients are inadequately treated.1,2 The first European guidelines specifically focused on ...

Date : 26/08/2011

Patients with diabetes and cardiovascular disease (myocardial infarction, angina pectoris or peripheral vascular disease) are at very high risk of recurrent cardiovascular disease. In patients with ...

Date : 31/08/2013

The Guidelines, which recommend several significant changes to hypertension treatment, are launched* today at the European Society of Hypertension congress in Milan, Italy, with simultaneous online ...

Date : 14/06/2013

At least 80% of CVD could be prevented by eliminating health risk behaviours. “Lipids are probably the most fundamental risk factor for CVD,” said Professor Ian Graham (Ireland), Task ...

Date : 27/08/2016

Patients with atherosclerosis in the leg arteries face a substantially increased all-cause and cardiovascular mortality risk, according to a large study presented at the European Society of ...

Date : 04/09/2007

PPCM at the time of giving birth is associated with a four to five times higher rate of stillbirth.” Dr Kao previously published a study in 4 million delivering mothers which identified age 30 ...

Date : 23/05/2015

EMBARGO : 30 August 2015 at 08:45 BST “This is the first study to show better outcomes using the 2012 ESC guidelines on atrial fibrillation,” said principal investigator Professor Gregory ...

Date : 30/08/2015

Sunday 31 August: The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and ...

Date : 31/08/2014